E-Z-EM (EZEM) Tops Q2 View
More News related to EZEM
- E-Z-EM (EZEM) Tops Q2 View
- E-Z-EM (EZEM) Acquired By Bracco Diagnostics for $21/Share
- E-Z-EM (EZEM) Reports Q1 EPS of $0.06; Guides
- Amerinet Adds E-Z-EM's mpowerMR Injector to Purchasing Contract
- E-Z-EM, Inc. (EZEM) Receives Additional $8 Million Order from USASMD
More News related to Earnings
- HNI Corporation (HNI) Tops Q1 EPS by 2c; Revs Light
- Team Health (TMH) Reports Mixed Q4 Results
- Baidu (BIDU) Blows the Lid Off Q4, Shares Jump
- Aspen Insurance (AHL) Posts Q4 adj.-EPS of $1.44, Tops Views
- Acadia Realty Trust (AKR) Misses Q4 FFO by 1c; Guides Below for FY10
E-Z-EM Inc. (Nasdaq: EZEM) reported Q2 EPS of $0.25, 5 cents better than the analyst estimate of $0.20. Revenues for the quarter were $43.6 million, versus the consensus of $39.60 million.
E-Z-EM, Inc., together with its subsidiaries, provides medical devices and contrast products used by radiologists, gastroenterologists, and speech language pathologists primarily in screening for and diagnosing diseases and disorders of the gastrointestinal (GI) tract.
Related Categories
EarningsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
